The Chinese Medicine Pharmacy Development Act (中醫藥發展法) was enacted in 2019 to bolster talent cultivation in Chinese medicine and pharmacy, enhance the quality of Chinese medicine healthcare, and protect the health and well-being of all nationals. Establishing a traditional Chinese medicine (TCM) specialist system (中醫專科醫師制度) is an important policy for implementing the above goals.
There are more than 20 academic groups related to TCM in Taiwan, all of which are committed to specific professional learning and development to provide patients with high-quality clinical care.
The mission of the Taiwan Association of Traditional Chinese Internal Medicine, which was established on July 12, 1998, is to “carry forward traditional Chinese medicine, strengthen research on Chinese internal medicine, and advance with the times, combined with modern medicine, to promote the well-being of all nationals.” Its members are committed to continuous learning and improvement in the field of traditional Chinese internal medicine to provide professional treatment for patients with internal diseases.
Chingguan Yihau (清冠一號), or NRICM101, is a traditional Chinese medicine developed by the National Research Institute of Chinese Medicine to treat COVID-19. It was the best evidence of specialized treatment in Chinese internal medicine.
Taiwan has 23 ministry-defined specialties for Western physicians and 11 ministry-defined specialties for dentists. However, there is no ministry-defined specialty for Chinese medicine practitioners, which runs counter to the idea of cultivating Chinese medicine talent and improving the quality of care stipulated in the Chinese Medicine Pharmacy Development Act.
At present, the only training for TCM practitioners is post-graduate general medical training similar to that of Western physicians and dentists, which focuses on two years of training to enable doctors to diagnose, treat and care for common and general diseases. There is a lack of follow-up specialist training for doctors-in-training to receive complete clinical professional training and continuous updates on the latest medical knowledge like those of Western doctors and dentists. This is not in line with the goal of improving the quality of TCM to promote the public’s well-being.
Setting up a TCM specialist training system would be a big step forward in the development of TCM and pharmacology in Taiwan. The TCM community can learn from the well-developed specialist system of Western doctors and dentists, and provide complete specialist training for resident doctors to improve the quality of TCM care.
A TCM specialist system is a policy that would benefit the country and the public. Well-intentioned politicians and doctors should work together to make it happen as soon as possible.
Hung Yu-chiang is the director of the Taiwan Association of Traditional Chinese Internal Medicine.
Translated by Lin Lee-kai
What began on Feb. 28 as a military campaign against Iran quickly became the largest energy-supply disruption in modern times. Unlike the oil crises of the 1970s, which stemmed from producer-led embargoes, US President Donald Trump is the first leader in modern history to trigger a cascading global energy crisis through direct military action. In the process, Trump has also laid bare Taiwan’s strategic and economic fragilities, offering Beijing a real-time tutorial in how to exploit them. Repairing the damage to Persian Gulf oil and gas infrastructure could take years, suggesting that elevated energy prices are likely to persist. But the most
Taiwan should reject two flawed answers to the Eswatini controversy: that diplomatic allies no longer matter, or that they must be preserved at any cost. The sustainable answer is to maintain formal diplomatic relations while redesigning development relationships around transparency, local ownership and democratic accountability. President William Lai’s (賴清德) canceled trip to Eswatini has elicited two predictable reactions in Taiwan. One camp has argued that the episode proves Taiwan must double down on support for every remaining diplomatic ally, because Beijing is tightening the screws, and formal recognition is too scarce to risk. The other says the opposite: If maintaining
Chinese Nationalist Party (KMT) Chairwoman Cheng Li-wun (鄭麗文), during an interview for the podcast Lanshuan Time (蘭萱時間) released on Monday, said that a US professor had said that she deserved to be nominated for the Nobel Peace Prize following her meeting earlier this month with Chinese President Xi Jinping (習近平). Cheng’s “journey of peace” has garnered attention from overseas and from within Taiwan. The latest My Formosa poll, conducted last week after the Cheng-Xi meeting, shows that Cheng’s approval rating is 31.5 percent, up 7.6 percentage points compared with the month before. The same poll showed that 44.5 percent of respondents
India’s semiconductor strategy is undergoing a quiet, but significant, recalibration. With the rollout of India Semiconductor Mission (ISM) 2.0, New Delhi is signaling a shift away from ambition-driven leaps toward a more grounded, capability-led approach rooted in industrial realities and institutional learning. Rather than attempting to enter the most advanced nodes immediately, India has chosen to prioritize mature technologies in the 28-nanometer to 65-nanometer range. That would not be a retreat, but a strategic alignment with domestic capabilities, market demand and global supply chain gaps. The shift carries the imprimatur of Indian Prime Minister Narendra Modi, indicating that the recalibration is
RSS